These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9134975)

  • 21. Involvement of amygdalar alpha adrenoceptors in hypothalamo-pituitary-adrenocortical responses.
    Feldman S; Weidenfeld J
    Neuroreport; 1996 Nov; 7(18):3055-7. PubMed ID: 9116239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of treatment with adrenocorticotrophin on the hypothalamo-pituitary-adrenal system.
    Stark E; Kárteszi M; Rappay G; Makara GB
    J Endocrinol; 1981 Jan; 88(1):131-9. PubMed ID: 6257818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid receptor antagonists in the hippocampus modify the negative feedback following neural stimuli.
    Feldman S; Weidenfeld J
    Brain Res; 1999 Mar; 821(1):33-7. PubMed ID: 10064785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation.
    Bradbury MJ; Akana SF; Dallman MF
    Endocrinology; 1994 Mar; 134(3):1286-96. PubMed ID: 8119168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexamethasone suppression of the effects of cocaine on adrenocortical secretion in Lewis and Fischer rats.
    Simar MR; Saphier D; Goeders NE
    Psychoneuroendocrinology; 1997 Apr; 22(3):141-53. PubMed ID: 9203225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence for the central effect of dexamethasone at the hypothalamic level in the negative feedback mechanism.
    Feldman S; Weidenfeld J
    Brain Res; 2002 Dec; 958(2):291-6. PubMed ID: 12470864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
    Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS
    Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
    Spencer RL; Kim PJ; Kalman BA; Cole MA
    Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of exogenous nitric oxide and inhibitors of nitric oxide synthase on the hypothalamic pituitary adrenal axis responses to neural stimuli.
    Weidenfeld J; Feldman S; DeKeyser FG; Ovadia H
    Neuroendocrinology; 1999 Sep; 70(3):153-9. PubMed ID: 10516477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
    Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats.
    Hinz B; Hirschelmann R
    Pharm Res; 2000 Oct; 17(10):1273-7. PubMed ID: 11145234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging.
    Hatzinger M; Reul JM; Landgraf R; Holsboer F; Neumann I
    Neuroendocrinology; 1996 Nov; 64(5):349-56. PubMed ID: 8930935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P; Anisman H; Merali Z
    Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress.
    Spencer SJ; Xu L; Clarke MA; Lemus M; Reichenbach A; Geenen B; Kozicz T; Andrews ZB
    Biol Psychiatry; 2012 Sep; 72(6):457-65. PubMed ID: 22521145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone.
    Gesing A; Bilang-Bleuel A; Droste SK; Linthorst AC; Holsboer F; Reul JM
    J Neurosci; 2001 Jul; 21(13):4822-9. PubMed ID: 11425909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.